Similarly, in leukemias associated with Pten chromosomal translocations, it has been repeatedly observed that inhibition of mTORC1 signaling by rapamycin delays the onset of leukemia and reduces tumor burden but it does not affect the leukemia stem cell. This evidence concerns the gene PTEN and neoplasm.